Clinical Trials · NCT03000946

Prevention of Postoperative Pancreatic Fistula by Somatostatin

CompletedPhase 3Octreotide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
655
Start date
May 2017
Locations
2 sites, France
Primary endpoint
≥ grade B or C postoperative pancreatic fistula as defined by the International Study Group of Pancreatic Fistula (ISGPF) classification
View Octreotide compound reference